Category Innovation/ R&D

WHO, WTO, WIPO Put Their Collective Mind To Antibiotic Resistance Calamity

Resistance to antibiotics by bacteria has been steadily growing and is now considered as a major threat to global public health, with some catastrophic projections of millions of death and billions of dollars in economic impact. The World Trade Organization, World Health Organization and World Intellectual Property Organization today are holding a joint technical symposium on antimicrobial resistance, and how to encourage innovation, appropriate use of antibiotics, and wide access to treatments and diagnostics.

US High Court Puts Unreasonable Delay On Trial

On its face, the case is a humdrum, procedural dispute about a patentee’s delay in filing an infringement suit. But if the Supreme Court rules the way most experts expect, the decision will significantly enhance the power of patent trolls and others alleging patent infringement, and it will harm many companies doing business in the US – especially companies in the tech sector. Much hangs in the balance on 1 November, when the Supreme Court hears oral arguments in SCA Hygiene Products AG v. First Quality Baby Products, LLC.

WIPO Wants Its Pro Bono Patent Lawyer Scheme To Aid Developing Countries’ Inventors

Imagine you’re an inventor in the Philippines and want to file a patent for, say, a fishing implement you’ve invented, but your $9,000 a year income thwarts your ability to pay the legal fees to register it and develop it commercially.

You could be stumped from the start.

WHO Pandemic Influenza Advisory Group Meeting In Secret This Week

The World Health Organization pandemic influenza framework advisory group is meeting this week, behind closed doors. A consultation is expected to take place on 20 October with stakeholders, and an information session has been organised on 21 October on the work of the advisory group, but no press is allowed in either meeting nor able to obtain any information about any aspect of the week’s events.

55 Civil Society Groups Ask US Government To Allow Export Of Affordable Version Of Prostate Cancer Drug Xtandi

A range of 55 civil society organisations from around the world today sent a letter asking the United States Department of Health and Human Services to accept an offer from a Canadian generics company, Biolyse Pharma, to manufacture and export high-priced cancer drug Xtandi to countries with a per capita income of less than one-third that of the United States.

FTC Recommends Legislative Fixes For Nuisance Patent Lawsuits But Some Question Study

LONDON -- Procedural and substantive legislative reforms are needed to keep nuisance patent infringement lawsuits at bay, the United States Federal Trade Commission said in an October report. The question is whether the size of the study on activities of “patent assertion entities” (PAEs) was large enough to prove there's a problem, say some patent attorneys, including speakers at the 13-14 October London IP Summit.

EPO Staff Seek WIPO-Style Disciplinary Guidelines As Reports Show High Levels Of Discontent

With management-staff relations at the European Patent Office still spiralling downward, staff members are pressing the office's governing council to consider adopting proposed disciplinary and investigation guidelines currently under discussion in the World Intellectual Property Organization.

“We Are Here Today To Be Optimistic”: Stories And Advice From Women In IP

Under the banner of “inclusive trade,” last week’s World Trade Organization Public Forum hosted an array of sessions to discuss how a wider range of individuals and businesses can participate in the trading system. One prominent subject of discussion therein is how women can overcome the constraints and obstacles preventing them from accessing and obtaining the benefits of trade, and participate more fully in the field of intellectual property.